Adam I. Edelstein

Adam I. Edelstein

Auto-generated profile, based on publicly available information

Adam I. Edelstein

Department of Orthopaedic Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2015 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
AEAdam I. Edelstein
Adam I. Edelstein
MKMary J. Kwasny
Mary J. Kwasny
LSLinda I. Suleiman
Linda I. Suleiman
RKRishi H. Khakhkhar
Rishi H. Khakhkhar
MMMichael A. Moore
Michael A. Moore
DMDavid W. Manning
David W. Manning

6 August 2014 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
PDF file
AEAdam I. Edelstein
Adam I. Edelstein
FLFrancis C. Lovecchio
Francis C. Lovecchio
SSSujata Saha
Sujata Saha
WHWellington K. Hsu
Wellington K. Hsu
JKJohn Y.S. Kim
John Y.S. Kim
Operative procedural training is a key component of orthopaedic surgery residency. The influence of intraoperative resident participation on the outcomes of surgery has not been studied extensively using large, population-based databases. We identified 30,628 patients who underwent orthopaedic procedures from the 2011 American College of Surgeons National Surgical Quality Improvement Program. Outcomes as measured by perioperative complications, readmission rates, and mortality within thirty days were compared for cases with and without intraoperative resident involvement. Logistic regression with propensity score analysis revealed that intraoperative resident participation was associated with decreased rates of overall complications (odds ratio, 0.717 [95% confidence interval, 0.657 to 0.782]), medical complications (odds ratio, 0.723 [95% confidence interval, 0.661 to 0.790]), and mortality (odds ratio, 0.638 [95% confidence interval, 0.427 to 0.951]). Resident presence in the operating room was not predictive of wound complications (odds ratio, 0.831 [95% confidence interval, 0.656 to 1.053]), readmission (odds ratio, 0.962 [95% confidence interval, 0.830 to 1.116]), or reoperation (odds ratio, 0.938 [95% confidence interval, 0.758 to 1.161]). A second analysis by propensity score stratification into quintiles grouped by similar probability of intraoperative resident presence showed resident involvement to correlate with decreased rates of overall and medical complications in three quintiles, but increased rates of overall and medical complications in one quintile. All other outcomes were equivalent across quintiles. Orthopaedic resident involvement during surgical procedures is associated with lower risk of perioperative complications and mortality in the National Surgical Quality Improvement Program database. The results support resident participation in the operative care of orthopaedic patients. Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

1 February 2018 in Spine
Verified
Journal Article
Closed access
PDF file
SLSeokchun Lim
Seokchun Lim
AEAdam I. Edelstein
Adam I. Edelstein
APAlpesh A. Patel
Alpesh A. Patel
BKBobby D. Kim
Bobby D. Kim
JKJohn Y.S. Kim
John Y.S. Kim
Retrospective multivariate analysis of a prospectively collected, multicenter database. To identify patient characteristics and perioperative risk factors associated with postoperative infectious complications after single-level lumbar fusion (SLLF) surgery. Postoperative infection is a known complication after lumbar fusion. Risk factors for infectious complications after lumbar fusion have not been investigated using select set of SLLF procedures. Patients who underwent SLLF between 2006 and 2011 were identified from the American College of Surgeons National Surgical Quality Improvement Program database. Multivariate logistic regression analyses were performed to identify pre- and intraoperative risk factors associated with postoperative infection. A total of 3353 patients were analyzed in this study. Overall, 173 (5.2%) patients experienced a postoperative infection, including 86 (2.6%) surgical site infections (SSIs) and 111 (3.3%) non-SSI infectious complications (pneumonia, urinary tract infection, sepsis/septic shock). Twenty-four (0.7%) patients experienced both SSI and non-SSI infectious complications. Postoperative SSI were associated with obesity (odds ratio [OR], 1.628; 95% confidence interval [CI], 1.042–2.544), American Society of Anesthesiologists class more than 2 (OR, 2.078; 95% CI, 1.309–3.299), and operative time more than 6 hours (OR, 2.573; 95% CI, 1.310–5.056). Risk factors for non-SSI infectious complications included age (60–69 yr; OR, 3.279; 95% CI, 1.541–6.980; and ≥70 yr; OR, 3.348; 95% CI, 1.519–7.378), female sex (OR, 1.791; 95% CI, 1.183–2.711), creatinine more than 1.5 mg/dL (OR, 2.400; 95% CI, 1.138–5.062), American Society of Anesthesiologists class more than 2 (OR, 1.835; 95% CI, 1.177–2.860), and operative time more than 6 hours (OR, 3.563; 95% CI, 2.082–6.097). Across a wide study population, we identified that obesity, advanced American Society of Anesthesiologists classification, and longer operative time were predictive of postoperative SSI. We also demonstrated that increased age, female sex, serum creatinine more than 1.5 mg/dL, and prolonged operative duration are associated with non-SSI infectious complications after SLLF. Continued efforts to elucidate and optimize perioperative risk factors are warranted to improve outcomes in patients requiring spinal fusion. Level of Evidence: 3

1 January 2016 in Journal of the American Academy of Orthopaedic Surgeons
Verified
Journal Article
Closed access
DMDavid W. Manning
David W. Manning
AEAdam I. Edelstein
Adam I. Edelstein
HAHasham M. Alvi
Hasham M. Alvi
The current healthcare environment in America is driven by the concepts of quality, cost containment, and value. In this environment, primary hip and knee arthroplasty procedures have been targeted for cost containment through quality improvement initiatives intended to reduce the incidence of costly complications and readmissions. Accordingly, risk prediction tools have been developed in an attempt to quantify the patient-specific assessment of risk. Risk prediction tools may be useful for the informed consent process, for enhancing risk mitigation efforts, and for risk-adjusting data used for reimbursement and the public reporting of outcomes. The evaluation of risk prediction tools involves statistical measures such as discrimination and calibration to assess accuracy and utility. Furthermore, prediction tools are tuned to the source dataset from which they are derived, require validation with external datasets, and should be recalibrated over time. However, a high-quality, externally validated risk prediction tool for adverse outcomes after primary total joint arthroplasty remains an elusive goal.

1 February 2017 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
PDF file
AEAdam I. Edelstein
Adam I. Edelstein
JWJoseph A. Weiner
Joseph A. Weiner
RCRalph W. Cook
Ralph W. Cook
DCDanielle S. Chun
Danielle S. Chun
EMEmily Monroe
Emily Monroe
EHErin L. Hsu
Erin L. Hsu
Background: Periprosthetic joint infection following hip and knee arthroplasty leads to poor outcomes and exorbitant costs. Topical vancomycin powder has been shown to decrease infection in many procedures such as spine surgery. The role of vancomycin powder in the setting of total joint arthroplasty remains undefined. Our aim was to evaluate the efficacy of intra-articular vancomycin powder in preventing infection in a rat model of a contaminated intra-articular implant.Methods: Thirty-two female Sprague-Dawley rats underwent knee arthrotomy and implantation of a femoral intramedullary wire with 1 mm of intra-articular communication. The knee joint was also inoculated with 1.5 × 107colony forming units (CFU)/mL of methicillin-resistantStaphylococcus aureus(MRSA). Four treatment groups were studied: (1) no antibiotics (control), (2) preoperative systemic vancomycin, (3) intra-articular vancomycin powder, and (4) both systemic vancomycin and intra-articular vancomycin powder. The animals were killed on postoperative day 6, and distal femoral bone, joint capsule, and the implanted wire were harvested for bacteriologic analysis. Statistical analyses were performed using Wilcoxon rank sum and Fisher exact tests.Results: There were no postoperative deaths, wound complications, signs of vancomycin-related toxicity, or signs of systemic illness in any of the treatment groups. There were significantly fewer positive cultures in the group that received vancomycin powder in combination with systemic vancomycin compared with the group that received systemic vancomycin alone (bone: 0% versus 75% of 8, p = 0.007; Kirschner wire: 0% versus 63% of 8, p = 0.026; whole animal: 0% versus 88% of 8, p = 0.01). Only animals that received both vancomycin powder and systemic vancomycin showed evidence of complete elimination of bacterial contamination.Conclusions: In a rat model of a contaminated intra-articular implant, use of intra-articular vancomycin powder in combination with systemic vancomycin completely eliminated MRSA bacterial contamination. Animals treated with systemic vancomycin alone had persistent MRSA contamination.Clinical Relevance: This animal study presents data suggesting that the use of intra-articular vancomycin powder for reducing the risk of periprosthetic joint infections should be investigated further in clinical studies.

1 February 2017 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
AEAdam I. Edelstein
Adam I. Edelstein
FLFrancis Lovecchio
Francis Lovecchio
DDDimitri E. Delagrammaticas
Dimitri E. Delagrammaticas
DFDavid W. Fitz
David W. Fitz
KHKevin D. Hardt
Kevin D. Hardt
DMDavid W. Manning
David W. Manning